August 29, 2018 comslyndra

Media

Media & events

PRESS RELEASES

2021

December 8, 2021 - Lyndra Therapeutics Appoints Klas Holmlund, CFA, as Chief Financial Officer

September 20, 2021 - Lyndra Therapeutics Advances Leadership in Key Roles

July 27, 2021 - Lyndra Therapeutics’ Investigational Oral, Weekly Opioid Use Disorder Treatment LYN-014 Granted Fast Track Designation by FDA

July 19, 2021 - Lyndra Therapeutics Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA for Lyndra’s Weekly Risperidone (LYN-005) for the Treatment of Adults with Schizophrenia and Other Indications

June 25, 2021-Lyndra Therapeutics Presents Preclinical Data on Once-Weekly Oral Buprenorphine Treatment, LYN-013, in Development for Opioid Use Disorder

June 24, 2021-Lyndra Therapeutics Completes $60.5 Million Series C Financing

May 6, 2021-Lyndra Therapeutics Receives FDA Clearance of Investigational New Drug Application for LYN-014, its Once-Weekly Oral Levomethadone Treatment in Development for Opioid Use Disorder

April 18, 2021-Lyndra Therapeutics Presents Promising Phase 2 Data on Once-Weekly Oral Risperidone Treatment, LYN-005, in Development for Schizophrenia

March 31, 2021 - Lyndra Therapeutics Appoints Abigail Jenkins as Chief Commercial and Business Officer and Jacqueline Fernandes as Vice President of Data Compliance and Information Technology

February 18, 2021 - Lyndra Therapeutics to Participate in the SVB Leerink 10th Annual Global Healthcare Conference

January 21, 2021 - Lyndra Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of Once-Weekly Rosuvastatin Extended-Release Capsule, LYN-047

2020

October 20, 2020 - Lyndra Therapeutics Appoints George A. Eldridge as Chief Financial Officer

June 10, 2020 - Lyndra Therapeutics Achieves Critical Milestones Despite COVID-19 Headwinds

February 11, 2020 - Lyndra Therapeutics Files IND, Bolsters Leadership Team and Readies for Manufacturing

read more

2019

July 30, 2019 - Lyndra Therapeutics to Develop Once-Monthly Oral Contraceptive

read more

July 8, 2019 - Lyndra Therapeutics and Gilead Sciences to Collaborate on Development of Ultra-Long-Acting HIV Therapeutics

read more

June 3, 2019 - Lyndra Therapeutics Welcomes Dr. Patricia Hurter as Chief Executive Officer

read more

April 9, 2019 - Lyndra Therapeutics Takes on Opioid Use Disorder with Long-Acting Oral Dosage Form

read more

February 11, 2019 - FUJIFILM Joins Lyndra Therapeutics’ Series B Raise, Bringing Total Round to $60 Million

read more

January 29, 2019 - Lyndra Therapeutics Raises $55 Million in Series B Financing

read more

2018

December 10, 2018 - Lyndra Therapeutics Announces Notice of Allowance on Patent Covering Long-acting Pill

read more

November 15, 2018 - Lyndra Therapeutics Reports Positive Results from Pharmacokinetics (PK) Study of its Ultra-long-acting Oral Dosage Form

read more

January 8, 2018 - Lyndra Announces Publication of Feasibility Study of Oral Once-Weekly Drug Delivery System for HIV Antiretroviral Therapy in Nature Communications

read more

2017

September 7, 2017 - Lyndra, Inc. and Allergan Sign a Partnership to Develop Ultra-Long-Acting Oral Products

read more

May 2, 2017 - Lyndra Secures Funding from the National Institute of Allergy and Infectious Diseases for the Development of Ultra-Long Acting Oral HIV Therapies

read more

April 13, 2017 - Lyndra, Inc. Raises $23 Million in Series A Financing to Advance Ultra-Long Acting Oral Therapeutic Delivery

read more

2016

November 16, 2016 - Scientists Develop Ultra Long-Acting Oral Drug Delivery Platform

read more

news

2021

How Lyndra Uses Trial Partners to Reinvent Medicine – Clinical Leader | June 11, 2021

read more

Once-Weekly Oral Antipsychotic for Schizophrenia on the Horizon – Medscape | June 03, 2021

read more

Lyndra’s ultralong-acting pill shows promise in schizophrenia phase 2, teeing up pivotal trial – FierceBiotech | April 18, 2021

read more

2020

Birth Control Pill Of The Future May Only Need To Be Taken Once A Month – WBUR | August 30, 2020

read more

Weekly Pill Formulation Could Help Treat Schizophrenia, HIV, Malaria and more – National Institutes of Health, Small Business Innovation Research | August 25, 2020

read more

Running the Operations of a Biotech Company That’s Transforming Oral Drug Delivery – Partnership Opportunities in Drug Delivery newsletter’s – Women Leadership in Drug Delivery Issue | July 16, 2020

read more

Changing the Pill: Tackling Medication Adherence Through Innovative Technology – National Center for Advancing Translational Sciences (NCATS) | March 17, 2020

read more

How Swallowing a Star Might Keep You From Missing a Dose of Medicine – Boston Globe | January 31, 2020

read more

Watertown startup unveils it’s new star – Boston Globe | January 16, 2020

read more

JPM: 4 women discuss culture shock between Big Pharma, smaller biotech and their first CEO role – FierceBiotech | January 16, 2020

read more

JPM: ‘An embarrassment of riches’—Lyndra CEO Hurter on the promise of ultralong-acting pills – FierceBiotech | January 16, 2020

read more

2019

Once-a-month contraceptive pill developed by scientists – The Guardian | December 6, 2019

read more

Researchers Make Progress Toward a Monthly Birth Control Pill – Time | December 6, 2019

read more

Once-a-month birth control pill? Experiment works in animals – AP News | December 6, 2019

read more

A Once-a-Month Birth Control Pill Is Coming—Here’s How It Works – Wired | December 5, 2019

read more

MIT researchers are developing a once-a-month birth control pill – Boston Globe | December 5, 2019

read more

Lyndra Pursues Once-a-Month Oral Contraceptive with $13M Gates Foundation Grant – Genetic Engineering and Biotechnology News | July 30, 2019

read more

Gates backs development work on a long-acting contraceptive pill – Endpoints | July 30, 2019

read more

Lyndra, Gates Foundation team up on once-a-month birth control – Boston Business Journal | July 30, 2019

read more

This company wants to make a once-a-month option for birth control pills – STAT | July 30, 2019

read more

Lyndra Therapeutics bags $13M Gates grant to develop once-monthly contraceptive pill – FierceBiotech | July 30, 2019

read more

Watertown biotech Lyndra teams up with Gilead in $15m deal to treat HIV – Boston Globe | July 9, 2019

read more

Gilead pays Watertown startup Lyndra $123M to develop longer-lasting HIV pill – Boston Business Journal | July 9, 2019

read more

Ex-Vertex Pharma Exec Patricia Hurter to Join Lyndra as CEO – Xconomy | June 5, 2019

read more

Lyndra Therapeutics’ incoming CEO is used to running tough races – Boston Globe | June 3, 2019

read more

Watertown biotech Lyndra snags longtime Vertex exec as CEO – Boston Business Journal | June 3, 2019

read more

Lyndra Announces Feasibility Study of Oral Once-Weekly HIV Drug – Daily Mail | January 9, 2019

read more

2018

Sick of a daily pill? A Boston biotech wants to make a daily Alzheimer’s drug last for a week — and they’re working on more – STAT | November 15, 2018

read more

Watertown biotech plans first clinical trial of weeklong schizophrenia drug – Boston Business Journal | November 15, 2018

read more

A Gates Foundation-Backed Startup Wants to Make Daily Pills a Thing of the Past – Business Insider | February 2, 2018

read more

Swallowing A ‘Mini-Pillbox’ Could Change The Way HIV Drugs Are Delivered – NPR | January 9, 2018

read more

Drug Capsule May Allow Weekly HIV Treatment –European Pharmaceutical Review | January 9, 2018

read more

Once-a-Week Pill for HIV – BBC | January 9, 2018

read more

2017

Alzheimer’s: Treating with a Daily Pill in the Future? – Fox Business News | September 7, 2017

read more

Watertown’s Lyndra Strikes Alzheimer’s Pact with Allergan Worth up to $105M – Boston Business Journal | September 7, 2017

read more

Watertown’s Lyndra Nabs $23M to Bankroll Long-Lasting Pill Tech – Boston Business Journal | April 13, 2017

read more

Lyndra’s Long-Acting Drug Delivery Technology Lands $23M Investment – Xconomy | April 13, 2017

read more

Lyndra Raises $23M in Series A to Progress Ultra-Long-Acting Oral Drug Delivery Tech – Genetic Engineering & Biotechnology News | April 13, 2017

read more

Lyndra Raises $23M in Series A to Progress Ultra-Long-Acting Oral Drug Delivery Tech – Genetic Engineering & Biotechnology News | April 13, 2017

read more

2016

Long-Lasting Pill that Releases Malaria Drug for Two Weeks a ‘Game-Changer’ – The Guardian| November 16, 2016

read more

Long-Lasting Pill to Replace Daily Dose – The Times | November 16, 2016

read more

How a Small Watertown Biotech is Trying to Make Oral Drugs Last Longer – Boston Business Journal | November 16, 2016

read more

‘Ultra-Long-Acting’ Pill Delivers Malaria Drug for 14 Days – FierceBiotech | November 16, 2016

read more